Patents by Inventor Sudhir Agrawal

Sudhir Agrawal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190220881
    Abstract: The present application provides systems, methods and computer readable media for creating and processing a digital voucher. The methods comprises a method for utilising a funding account of a first user to create a digital voucher having a value for a second user, the digital voucher being usable by the second user for remitting one or more transactions across participating parties that communicate with a payment network, the method comprising: generating, at a server for creating the digital voucher, a unique code of the digital voucher upon verification of a sufficient balance in the funding account, the unique code identifying an issuer party of the funding account and a payment network provider of the payment network, wherein the unique code is associated with a unique identifier of the second user.
    Type: Application
    Filed: January 15, 2019
    Publication date: July 18, 2019
    Applicant: Mastercard International Incorporated
    Inventors: Sudhir Gupta, Partho Sarothi Roy, Lloyd Fernandes, Rahul Agrawal, Lakshmi Narasimhan Ramanujam, Krutika Eknath Gonnade, Abhishek Chaturvedi, Ketan Shrikant Joshi, Gaurav K. Patni
  • Publication number: 20190197610
    Abstract: According to a first aspect, there is provided an offer-and-acceptance matching server comprising: at least one processor; at least one memory including computer program code; and a communication port coupled to the processor the at least one memory and the computer program code configured to, with the at least one processor, cause the offer-and-acceptance matching server at least to: receive, through the communication port, a query to determine deals for fund offer, fund acceptance, or both, available within a provided distance; interrogate a database to determine one or more fund offer deals, one or more fund acceptance deals, or both that match the query, the database containing records of such deals registered with the database; and respond, through the communication port, to the query with the deals that are within the provided distance.
    Type: Application
    Filed: September 25, 2018
    Publication date: June 27, 2019
    Inventors: Ashutosh Subhash GIJARE, Krishna Prasad VASIREDDY, Moreshwar Mukund DATYE, Rahul AGRAWAL, Sudhir GUPTA
  • Publication number: 20190197543
    Abstract: Methods and devices for authenticating a user are provided. The method for authenticating a user may include: providing a question to the user; receiving an answer to the question from the user; comparing the answer with a preference of the user; and authenticating the user based on the comparing. At least one of the question or the preference is determined based on at least one of circumstantial data of the user, a transaction data associated with the user, and feedback data from the user.
    Type: Application
    Filed: October 17, 2018
    Publication date: June 27, 2019
    Inventors: Sudhir Gupta, Rahul Agrawal
  • Publication number: 20190180356
    Abstract: A method of sharing of a product among a plurality of users includes receiving a first request, by a server, for accessing a merchant website from a first user. The first user accesses the merchant website to select a first product for sharing. The first user submits one or more product sharing parameters for sharing the first product to the server. The server receives a second request for accessing the merchant web site from a second user. The second user accesses the merchant web site to purchase the first product. The second user selects the first user to share the first product with, on time-shared basis. The server charges the first and second users the first offer amount and a purchase amount, respectively, to enable sharing of the first product between the first and second users.
    Type: Application
    Filed: December 4, 2018
    Publication date: June 13, 2019
    Inventors: Harsh PIPARSANIYA, Sudhir GUPTA, Rahul AGRAWAL
  • Publication number: 20190138708
    Abstract: Data processing systems and methods for authenticating users and for generating user authentication indications is disclosed. In one embodiment, a data processing system for authenticating a user, comprises: a computer processor and a data storage device, the data storage device storing instructions operative by the processor to: receive a user indication identifying a user; receive an authentication indication for the user, the authentication indication comprising a sequence of word-gesture pair indications, each word-gesture pair indication comprising a word indication and a gesture indication; look up a stored authentication indication for the user; compare the received authentication indication with the stored authentication indication; and generate an authentication result indication indicating the result of the comparison.
    Type: Application
    Filed: October 24, 2018
    Publication date: May 9, 2019
    Inventors: Rahul Agrawal, Sudhir Gupta
  • Patent number: 10066230
    Abstract: The invention provides immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: September 4, 2018
    Assignee: Idera Pharmaceuticals, Inc.
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Dong Yu, Ireneusz Nowak, Sudhir Agrawal
  • Patent number: 10041076
    Abstract: The invention provides immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: August 7, 2018
    Assignee: Idera Pharmaceuticals, Inc.
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Dong Yu, Ireneusz Nowak, Sudhir Agrawal
  • Publication number: 20180125877
    Abstract: The present invention relates to methods for treating a tumor, including a metastatic tumor, with TLR9 agonist in combination with an immune checkpoint inhibitor therapy.
    Type: Application
    Filed: September 15, 2017
    Publication date: May 10, 2018
    Inventors: Sudhir AGRAWAL, Daqing JIANG, Wayne JIANG
  • Publication number: 20180044669
    Abstract: The present invention is directed to compounds, compositions, and methods useful for modulating PD1, PDL1, IDO1, LAG3, TIM3, CTLA4, IDO2, CEACAM1, OX40, and/or OX40L mRNA or protein expression using gene silencing compounds comprising two or more single stranded antisense oligonucleotides that are linked through their 5?-ends to allow the presence of two or more accessible 3?-ends.
    Type: Application
    Filed: October 26, 2017
    Publication date: February 15, 2018
    Inventors: Sudhir AGRAWAL, Wayne JIANG, Daqing Wang, Jessica Seitzer, Fu-Gang Zhu, Xianzhi Mao
  • Publication number: 20180023085
    Abstract: The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Application
    Filed: October 6, 2017
    Publication date: January 25, 2018
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Ireneusz Nowak, Sudhir Agrawal
  • Patent number: 9828601
    Abstract: The present invention is directed to compounds, compositions, and methods useful for modulating PD1, PDL1, IDO1, LAG3, TIM3, CTLA4, IDO2, CEACAM1, OX40, and/or OX40L mRNA or protein expression using gene silencing compounds comprising two or more single stranded antisense oligonucleotides that are linked through their 5?-ends to allow the presence of two or more accessible 3?-ends.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: November 28, 2017
    Assignee: IDERA PHARMACEUTICALS, INC.
    Inventors: Sudhir Agrawal, Wayne Jiang, Daqing Wang, Jessica Seitzer, Fu-Gang Zhu, Xianzhi Mao
  • Publication number: 20170274004
    Abstract: The invention provides methods of inducing an immune response to cancer comprising co-administering to a cancer patient one or more TLR9 agonists and one or more checkpoint inhibitors. Preferably, the one or more TLR9 agonists are administered to the patient via intratumoral (i.t.) administration.
    Type: Application
    Filed: June 6, 2017
    Publication date: September 28, 2017
    Inventors: Daqing Wang, Wayne Jiang, Sudhir Agrawal
  • Publication number: 20170268006
    Abstract: The invention provides antagonist of TLR9 and methods of use thereof. These compounds inhibit or suppress TLR9-mediated signaling. The methods may have use in the prevention and treatment of diseases or disorders mediated by TLR9.
    Type: Application
    Filed: May 25, 2017
    Publication date: September 21, 2017
    Inventors: Sudhir Agrawal, Daqing Wang, Fu-Gang Zhu
  • Publication number: 20170233741
    Abstract: The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Application
    Filed: December 1, 2016
    Publication date: August 17, 2017
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Ireneusz Nowak, Sudhir Agrawal
  • Patent number: 9688993
    Abstract: The invention provides antagonist of TLR9 and methods of use thereof. These compounds inhibit or suppress TLR9-mediated signaling. The methods may have use in the prevention and treatment of diseases or disorders mediated by TLR9.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: June 27, 2017
    Assignee: IDERA PHARMACEUTICALS, INC.
    Inventors: Sudhir Agrawal, Daqing Wang, Fu-Gang Zhu
  • Publication number: 20170145417
    Abstract: The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Application
    Filed: August 16, 2016
    Publication date: May 25, 2017
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Yukui Li, Dong Yu, FuGang Zhu, Lakshmi Bhagat, Sudhir Agrawal
  • Publication number: 20170145412
    Abstract: The present invention is directed to compounds, compositions, and methods useful for modulating NLRP3 mRNA or protein expression using gene silencing compounds comprising two or more single stranded antisense oligonucleotides that are linked through their 5?-ends to allow the presence of two or more accessible 3?-ends.
    Type: Application
    Filed: November 2, 2016
    Publication date: May 25, 2017
    Inventors: Weiwen Jiang, Mallikarjuna R. Putta, Fu-Gang Zhu, Jillian M. DiMuzio, Lakshmi Bhagat, Sudhir Agrawal
  • Publication number: 20170009230
    Abstract: The present invention is directed to compounds, compositions, and methods useful for modulating DUX4 mRNA or protein expression using gene silencing compounds comprising two or more single stranded antisense oligonucleotides that are linked through their 5?-ends to allow the presence of two or more accessible 3?-ends.
    Type: Application
    Filed: July 7, 2016
    Publication date: January 12, 2017
    Inventors: Sudhir Agrawal, Lakshmi Bhagat, Fu-Gang Zhu
  • Patent number: 9540651
    Abstract: The invention provides novel immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit or suppress TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: January 10, 2017
    Assignee: Idera Pharmaceuticals, Inc.
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Ireneusz Nowak, Sudhir Agrawal
  • Publication number: 20160312225
    Abstract: The invention provides immune regulatory oligonucleotides (IRO) as antagonist of TLRs and methods of use thereof. These IROs have unique sequences that inhibit TLR-mediated signaling in response to a TLR ligand or TLR agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, allergy, asthma or a disease caused by a pathogen.
    Type: Application
    Filed: July 13, 2016
    Publication date: October 27, 2016
    Inventors: Ekambar R. Kandimalla, Daqing Wang, Dong Yu, Ireneusz Nowak, Sudhir Agrawal